The targeted intervention of HERC3 at the early stage of CRC may reverse the progression of colorectal cancer, and targeted intervention of HERC3 at the progressive stage of CRC may also help in the treatment of CRC, so there is great potential value for the research and subsequent clinical translation of HERC3-targeted drugs. This evidence concerns the gene HERC3 and colorectal cancer.